Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1060650

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Accident and Emergency Departments: Greater London
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help achieve the 95 per cent four hour A&E waiting time target in (a) Lewisham borough and (b) London.
	tabling member constituency	Lewisham, Deptford
	tabling member printed	Vicky Foxcroft
	uin	220972
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>NHS Improvement is working closely with Lewisham and Greenwich NHS Trust to achieve delivery of the 95% four hour accident and emergency (A&amp;E) standard. Several steps are in place to support the Trust, including monthly oversight meetings between NHS Improvement’s senior leadership team and the Trust’s chief executive team to review performance; provision of NHS Improvement staff for on-site support to review long-stay patients and discharge those who are medically fit to be discharged; and work with mental health providers and the London Ambulance Service to support appropriate placement of mental health patients as well as improve patient handover performance. The Trust also received £500,000 of capital to develop and open a crisis café at the University Hospital Lewisham site, to help prevent avoidable mental health attendances at A&amp;E.</p><p>There are multiple actions underway to support reductions in waiting times for patients in London Emergency Departments. The London Urgent and Emergency Care programme and the Emergency Care Intensive Support Team provide dedicated expertise and support to several trusts<ins class="ministerial"><sup>1</sup></ins>. In addition, circa £26 million of extra capital investment was allocated to trusts across London to increase beds, emergency department capacity, same day emergency care and acute mental health services ahead of winter.</p><p> </p><p><ins class="ministerial"><sup>1</sup>Lewisham and Greenwich, Kings’ College Hospital, Hillingdon, London North West, Imperial, Barking Havering and Redbridge, Barts, Whittingdon, North Middlesex and University College London Hospital.</ins></p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 21/02/2019 15:18:21 question first ministerially corrected 21/02/2019 16:45:31 answering member 1585 label Biography information for Stephen Hammond previous answer version 103655 answering member constituency Wimbledon answering member printed Stephen Hammond answering member 1585 label Biography information for Stephen Hammond
	tabling member	4491 label Biography information for Vicky Foxcroft

1060592

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many weeks’ worth of medicines the Government has asked pharmaceutical companies to stockpile as part of preparations for the UK leaving the EU without a deal; and how his Department decided on that period of duration.
	tabling member constituency	Enfield, Southgate
	tabling member printed	Bambos Charalambous
	uin	220998
	answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>We understand that breast cancer drugs are vitally important to many people in this country. Our ‘no deal’ European Union exit contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/European Economic Area (EEA), to ensure that the supply of breast cancer drugs and other essential medicines to patients is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from or via the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in a ‘no deal’ scenario. The duration of the stockpiling requirement was based on the Government’s reasonable worst-case scenario border disruption planning assumptions.</p><p> </p><p>We also recognise that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of the no deal exit.</p><p> </p><p>The Department is unable to discuss specific medicines because to we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme, in order to reassure participating companies. This means not introducing information about a specific company, medicine, or a supply route into the public domain or to a third party.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 221000 question first answered 18/02/2019 15:19:26 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4610 label Biography information for Bambos Charalambous

1060593

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has in place to (a) (i) monitor and (ii) identify gaps in the medicines being stockpiled by pharmaceutical companies and (b) protect the supply of medicines not being stockpiled by pharmaceutical companies.
	tabling member constituency	Enfield, Southgate
	tabling member printed	Bambos Charalambous
	uin	220999
	answer	answer is ministerial correction date of answer 22/02/2019 answer text <p>In August 2018, the Department asked suppliers to confirm arrangements in respect of prescription-only and pharmacy medicines that come from or via the European Union /European Economic Area. Company responses have provided the Department with an indication of industry’s ability and preparedness to stockpile six weeks’ worth of additional supply of each of the in-scope medicines in the United Kingdom ahead of 29 March 2019.</p><p>Since then, we have continued to receive very good engagement and are working closely with industry on a product-by-product basis. Companies share our aims of ensuring continuity of medicines supply for patients is maintained and that suppliers are able to cope with any potential delays at the border that may arise in the short term in a ‘no deal’ scenario.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 22/02/2019 11:59:04 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4610 label Biography information for Bambos Charalambous

1060594

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what information he holds on those NHS breast cancer drugs that pharmaceutical companies will have six weeks' supply of by 29 March 2019.
	tabling member constituency	Enfield, Southgate
	tabling member printed	Bambos Charalambous
	uin	221000
	answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>We understand that breast cancer drugs are vitally important to many people in this country. Our ‘no deal’ European Union exit contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/European Economic Area (EEA), to ensure that the supply of breast cancer drugs and other essential medicines to patients is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from or via the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in a ‘no deal’ scenario. The duration of the stockpiling requirement was based on the Government’s reasonable worst-case scenario border disruption planning assumptions.</p><p> </p><p>We also recognise that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of the no deal exit.</p><p> </p><p>The Department is unable to discuss specific medicines because to we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme, in order to reassure participating companies. This means not introducing information about a specific company, medicine, or a supply route into the public domain or to a third party.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220998 question first answered 18/02/2019 15:19:26 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4610 label Biography information for Bambos Charalambous

1060618

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Brexit
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the cost to the public purse of his Department's preparations for the UK leaving the EU without a deal.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	220768
	answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Of the £71.1 million funding the Department has been allocated for 2018/19 and 2019/20 for preparations for European Union exit, we are unable to provide a breakdown of the amount of funding allocated to ‘no deal’ preparations specifically, as this cannot be separated from EU exit work as a whole across the Department.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 15:21:35 answering member 1585 label Biography information for Stephen Hammond
	tabling member	308 label Biography information for Mr Jim Cunningham

1060620

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: British Nationals Abroad
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the advice issued on 28 January 2019 entitled New advice for travellers visiting the UK, European Union or European Economic Area in the event of a no-deal EU exit, what advice he has for people on kidney dialysis who wish to travel in the EU or EEA and to whom his advice of 28 January 2019 does not cover because dialysis is not covered under travel insurance.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	220902
	answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.</p><p> </p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p><p> </p><p>People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a ‘no-deal’ scenario and so that they are aware of and can agree to any potential charges before booking travel.</p><p> </p><p>Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220903 220904 question first answered 18/02/2019 15:22:51 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4127 label Biography information for Julie Elliott

1060621

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: British Nationals Abroad
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the advice issued on 28 January 2019 entitled New advice for travellers visiting the UK, European Union or European Economic Area in the event of a no-deal EU exit, when he will issue an update to that advice for people on kidney dialysis who wish to travel to the EU or EEA.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	220903
	answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.</p><p> </p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p><p> </p><p>People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a ‘no-deal’ scenario and so that they are aware of and can agree to any potential charges before booking travel.</p><p> </p><p>Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220902 220904 question first answered 18/02/2019 15:22:51 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4127 label Biography information for Julie Elliott

1060622

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: British Nationals Abroad
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what advice he has on compensation to people on dialysis who book, or who have already booked, travel to the EU or EEA and who have to cancel it because they are unable to secure State-funded dialysis treatment whilst they are away.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	220904
	answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.</p><p> </p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p><p> </p><p>People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a ‘no-deal’ scenario and so that they are aware of and can agree to any potential charges before booking travel.</p><p> </p><p>Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220902 220903 question first answered 18/02/2019 15:22:51 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4127 label Biography information for Julie Elliott

1060643

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the UK leaving the EU on 29 March 2019 on the supply of medicines to the UK for NHS use.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	220816
	answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Our number one priority is to ensure patients continue to have unhindered access to medicines as we exit the European Union and we are working with all sectors in the supply chain to ensure this happens.</p><p> </p><p>The Government remains committed to leaving the EU with a deal. Under the conditions of the Withdrawal Agreement, there will be a two-year Implementation Period within which the Government will negotiate the United Kingdom’s future relationship with the EU. During the Implementation Period, there will be no change to the current trading arrangements with the EU/European Economic Area (EEA), meaning the supply of medicines and medical products will continue unhindered.</p><p> </p><p>As a responsible Government, we are planning for all possible exit scenarios, including ‘no deal’. Our ‘no deal’ medicines supply contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/ EEA to ensure that the supply of essential medicines, is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019. The response from industry has been very positive. The vast majority of companies have confirmed stockpiling plans are in place.</p><p> </p><p>On 7 December, the Government published updated reasonable worst-case scenario border disruption planning assumptions in the event of a ‘no deal’ EU exit. Medicines and medical products are prioritised in cross-Government planning, and the Department is working with relevant partners across Government and industry to ensure we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely into the UK.</p><p> </p><p>We are confident that if everyone does what they need to do, supplies will continue unhindered. The Department does not expect to see significant changes to existing medicine supply chains or capacity in the intervening period between now and 29 March 2019, although we will be monitoring this closely.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 15:10:21 answering member 1585 label Biography information for Stephen Hammond
	tabling member	1400 label Biography information for Kevin Brennan

1060653

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicine: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential effect on health research of the UK leaving the EU without a deal.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	220770
	answer	answer is ministerial correction date of answer 22/02/2019 answer text <p>The Government has stated its aim to establish a far-reaching science and innovation pact with the European Union, facilitating the exchange of ideas and researchers, and enabling the United Kingdom to participate in key programmes alongside our EU partners.</p><p>The Government is committed to securing a Withdrawal Agreement with the EU. However, as a responsible Government, we continue to prepare for all scenarios, including ‘no deal’. As part of these preparations, the Government is working across a range of workstreams to understand the potential effect of the UK leaving the EU without a deal, and to ensure that the UK has the best possible environment for basic, biomedical, health, and life sciences research. This includes access to and mobility of research leaders and the technical and research delivery workforce; access to EU research funding; the regulation of clinical trials, data and devices; rare diseases research; and clinical trials supplies in a ‘no deal’ scenario.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 22/02/2019 07:32:01 answering member 1585 label Biography information for Stephen Hammond
	tabling member	308 label Biography information for Mr Jim Cunningham